V

Verily

Precision health tech leveraging data science

Head of Real Estate & Workplace Services

Full-Time
$158k - $237k+ Bonus + Equity
Expert
Bachelor's
Dallas, TX, USA
Hybrid
Facilities OperationsFacilities Management

About the job

Requirements
  • A bachelor's degree in a relevant field and 15 or more years of business experience, including 10 or more years leading real estate, facilities, environmental health and safety, or workplace services.
  • Experience managing multi-site, rapid-growth environments spanning office, lab, depot, and manufacturing spaces.
  • A proven track record in strategic planning, daily operational management, and safety-conscious execution while prioritizing and driving progress across multiple complex tracks in a fast-paced environment.
  • Business partnering, presentation, and influencing skills, with the ability to guide decision-making and lead discussions at the C-suite level.
Responsibilities
  • Oversee the Transaction Management program, partnering with broker teams to assess site requirements, evaluate opportunities, and negotiate lease terms.
  • Lead annual operational budget development, resource allocation, and continuous cost-effectiveness strategies across the global facility portfolio in partnership with Finance, Legal, and Alphabet stakeholders.
  • Manage domestic and international service providers, contractors, procurement, and contracts to deliver high-quality, cost-effective solutions, including 24/7/365 maintenance and redundancy planning.
  • Build relationships with key business partners to understand requirements, deliver optimized solutions, and proactively provide timely new capabilities for business, engineering, and operations teams.
  • Partner across internal and external functions—including Legal, Procurement, Security, and Operations—to manage portfolio risks, compliance, and operational alignment.
Desired Qualifications
  • Success building and developing high-performing real estate and workplace services teams across complex, multi-site global geographies, ideally guiding a company from early-stage research and development through to a mature operating entity.
  • Advanced project/portfolio management and analytical skills, including familiarity with international, federal, and state financial, legal, and regulatory considerations in real estate and facilities management.

About the company

V

Verily

View
cbWebsite

Verily Life Sciences uses data science and clinical expertise to improve health outcomes through precision health. It combines medical, lifestyle, and environmental data to tailor interventions, offering products like the Baseline Platform for clinical research and COVID-19 testing, care management solutions, and medical devices. It differentiates itself by integrating diverse data at scale, pursuing health equity through Onduo, and collaborating with public sector partners while maintaining strong data security and privacy. The goal is to uncover new health insights and bring precision health to everyone, improving health outcomes across populations.

Company Size

1,001-5,000

Company Stage

Late Stage VC

Total Funding

$3.8B

Headquarters

Dallas, Texas

Founded

2015

Get referred to Verily

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • March 19, 2026 funding gives Verily $300 million to scale AI-native precision health.
  • Verily Workbench launched on AWS, expanding access for life sciences and government researchers.
  • Segmed’s April 30, 2026 imaging partnership broadens Pre Exchange’s research datasets and monetization paths.

What critics are saying

  • Ryan Sloan’s HIPAA lawsuit survived dismissal on September 11, 2025, exposing trust damage.
  • June 9, 2026 layoffs of 58 employees signal continued reorganization and weak operating leverage.
  • Alphabet’s control exit forces Verily to prove standalone demand before the new capital runs out.

What makes Verily unique

  • Verily Health Inc. pairs multimodal health data, AI, and clinical workflows across Pre and Workbench.
  • Its March 19, 2026 $300 million round reduced Alphabet to a minority investor.
  • Samsung, Salesforce, and NIH All of Us integrations deepen Verily’s data distribution.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Company Equity

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

0%
Yahoo Finance
Sep 9th, 2026
NVIDIA and CU Healthcare Innovation Fund invest in Verily Health's AI platform expansion

Verily Health has secured additional investment from NVIDIA and existing backer CU Healthcare Innovation Fund II. The funding extends Verily's March fundraising round. Current investors include Alphabet, Series X Capital, and UCHealth. The investment supports scaling of Verily's Pre Platform, a data and AI platform helping healthcare organisations deploy AI across research and care. It also backs Verily Me, the company's patient engagement offering. Verily and NVIDIA previously announced a collaboration in October 2025. Researchers using the Pre Platform can leverage NVIDIA AI libraries and B200 GPUs. Verily developed Forecast 1.0, a foundation model integrating genomics and electronic health record data to predict long-term health risks, using NVIDIA's AI stack.

University of Bath
Aug 26th, 2026
Global initiative will harness wastewater as an early warning system for public health protection.

Global initiative will harness wastewater as an early warning system for public health protection. Labs across the world will collect wastewater samples on Global Wastewater Day in 2027 to generate a unique snapshot of international public health. * Press release * Published on Wednesday 26 August 2026 * Last updated on Wednesday 26 August 2026 * View more announcements in Communications Researchers from CWBE at the University of Bath partnered with Bangor University have launched Global Wastewater Day (GWD), a pioneering international initiative to harness wastewater as an early warning system for future pandemics. The initiative will bring together scientists, governments, water utilities and public health organisations from around the world to establish one of the first coordinated global wastewater intelligence networks to transform wastewater from an overlooked by-product into one of the world's most powerful tools for understanding public health, environmental change and emerging global risks. The initiative aims to create a simultaneous global snapshot of health and environmental conditions through wastewater analysis, generating new insights to strengthen disease surveillance, track antimicrobial resistance, protect the environment and improve pandemic preparedness. Professor Davey Jones, from Bangor University (Wales), who is the leading the partnership, launched the initiative at the World Water Week conference in Stockholm, which brought together experts, policymakers, businesses and international organisations from across the globe. The project will coordinate a single, global day of wastewater sampling on 31 March 2027, with participating partners analysing wastewater at host labs across the world. Professor Barbara Kasprzyk-Hordern, Global Wastewater Day co-chair and Director of the University of Bath's Centre of Excellence in Water-Based Early-Warning Systems for Health Protection (CWBE), will provide the steer and deliver the chemical analysis programme of global wastewater samples with centre's new cutting-edge mass spectrometry facility. Professor Julie Barnett, Social Sciences Lead at CWBE, has also joined GWD steering committee to coordinate the ethical oversight of the initiative. The aim is to generate the first synchronised snapshot of global public health using wastewater-based epidemiology (WBE). Using established and cutting-edge methods, the programme will focus on detecting antimicrobial resistance (AMR), pathogens, pharmaceuticals, chemical indicators and other markers of human health. The initiative is being delivered in partnership between the University of Bath, Bangor University, Verily Health, the Global Consortium for Wastewater and Environmental Surveillance for Public Health (GLOWACON), the European Commission Joint Research Centre, and a growing international consortium of scientific and public health organisations. By capturing comparable information from communities around the world, Global Wastewater Day seeks to establish a new global benchmark for monitoring health and environmental change. With over 31 countries signed up to date, the initiative's long-term ambition is to create a "Planetary Health Observatory" where wastewater becomes a routine source of intelligence for understanding the interconnected health of people, animals and the environment. Professor Barbara Kasprzyk-Hordern, Director of CWBE at the University of Bath, said: "I am delighted to see this unique initiative moving forward. "Global Wastewater Day provides an important opportunity to highlight the vital role of Wastewater-Based Epidemiology in protecting public health, safeguarding the environment, and driving sustainable innovation. "As a powerful tool for monitoring population health and environmental trends, wastewater analysis will deliver actionable insights that support evidence-based decision-making and help build more resilient and sustainable communities worldwide. "With cutting-edge analytical capabilities we will generate unprecedented insights into population health, including the burden of non-communicable diseases such as diabetes and cardiovascular disease, dietary and nutritional patterns, and exposure to hazardous chemicals, including PFAS." Davey Jones, Professor of Environmental Science and Public Health at Bangor University, said: "Everything Bath do in society leaves a footprint in its wastewater. "With Global Wastewater Day Bath want to harness the information it provides to supercharge public health research across the world, helping Bath detect emerging threats earlier and build a stronger early-warning system for future pandemics. "The initiative will enable a global comparison of public health data using standardised methods, while building a long-term resource through annual repeat sampling and an open-access dataset. "A core principle of the project is accessibility and inclusivity, with a strong emphasis on supporting participation from low- and middle-income countries. "Bath want to encourage as many scientists, organisations and communities as possible to get involved, contribute data and expertise, and share the initiative with colleagues and networks who may be interested. "By working across borders, we have an unprecedented opportunity to transform wastewater from an overlooked resource into a source of global intelligence, helping to protect populations, strengthen resilience and support better decision-making for future generations." Organisations and researchers are invited to register their interest in taking part in Global Wastewater Day. Media enquiries.

MPO Magazine
May 28th, 2026
Verily raises $300M to advance AI precision health platform

Verily has raised $300 million in a funding round led by Series X Capital, with participation from Alphabet, UCHealth, the University of Colorado Anschutz and others. Alphabet remains a significant minority investor but no longer holds a controlling stake in the precision health AI company. The investment marks Verily's transition from an LLC to a corporation, now officially named Verily Health Inc. The funds will accelerate its AI-native precision health platform strategy, helping customers harmonise healthcare data and deploy actionable intelligence into research and care workflows. Verily recently announced partnerships with Samsung's Galaxy Watch and Salesforce's Agentforce Health. The company, which graduated from Google X 10 years ago as one of Alphabet's earliest ventures, aims to make healthcare more personalised, predictive and precise through AI-powered solutions.

FCC Singapore
May 26th, 2026
Verily, a Google subsidiary, expands its mosquito factory in Singapore to strengthen dengue control.

Verily, a Google subsidiary, expands its mosquito factory in Singapore to strengthen dengue control. 26 May 2026 [PHOTO: The Straits Times] Market Info | Health & Lifestyle | Public Health Date: 1 June 2026 Region: ASEAN-O Country: Singapore Sector: Health & Lifestyle Sub-sector: Public Health Section: Market Trends Theme: Combating Infectious Diseases Verily, a subsidiary of tech giant Google, has announced a significant expansion of its sterile mosquito production facility in Singapore, marking a major milestone in the fight against dengue. This initiative leverages cutting-edge technology where sterile male mosquitoes are bred and released into the wild to mate with wild females, thereby reducing the population of mosquitoes capable of transmitting diseases like dengue. This method, known as the Sterile Insect Technique (SIT), is an eco-friendly alternative to traditional pesticides and aligns with a sustainable approach to vector control. The expansion of this facility in Singapore reflects the country's commitment to strengthening its public health capabilities in the face of challenges posed by vector-borne diseases. Dengue, in particular, remains a major concern in the region, with thousands of cases reported annually. By adopting this innovative technology, Singapore demonstrates its determination to combine science and public health to protect its population. This approach also aligns with the broader objectives of the Healthier SG strategy, which aims to enhance the resilience of the healthcare system against emerging threats. Furthermore, this initiative positions Singapore as a regional leader in biotechnology applied to public health. By collaborating with international players like Verily, the country strengthens its ability to innovate and attract investments in sustainable health solutions. Verily's sterile mosquito factory in Singapore could also serve as a model for other countries in the region facing similar challenges with mosquito-borne diseases. This expansion is a tangible example of how Singapore is leveraging technology and innovation to address complex public health challenges while contributing to global solutions for infectious disease control.

MPO Magazine
Apr 30th, 2026
Segmed, Verily band together to expand access to real-world imaging data.

Segmed, Verily band together to expand access to real-world imaging data. Pairing aims to to support patient-centered, data-driven healthcare innovation. April 30, 2026 Managing Editor Segmed Inc. is partnering with Verily to increase access to de-identified imaging datasets. Through the collaboration, Segmed is making its de-identified, diagnostic-grade imaging and associated clinical data more available by enabling researchers to explore curated datasets within Verily's precision health platform, Pre Exchange and Workbench environment, secure platforms designed to accelerate precision health research and discovery. The partnership reflects Segmed's commitment to supporting rigorous, privacy-first research while lowering barriers to entry for investigators across academia, life sciences, and healthcare artificial intelligence (AI), Segmed executives claim. "Advanced imaging data plays a critical role in precision medicine, particularly when combined with clinical and other biomedical data modalities," Segmed CEO David Gascoigne said. "By partnering with Verily, we're expanding responsible access to high-quality, de-identified imaging datasets, helping researchers generate insights faster to accelerate the development of diagnostics and therapies." Segmed's initial dataset available through Pre Exchange focuses on breast cancer and includes a longitudinal cohort of patients who underwent at least one digital breast tomosynthesis (DBT) exam and biopsy-proven malignant lesions. This dataset is drawn from Segmed's broader global imaging platform, which includes approximately 150 million de-identified imaging exams spanning modalities such as CT, MRI, X-ray, ultrasound, mammography, PET, SPECT, echocardiography, and DEXA. "This partnership with Segmed is an important step forward in advancing AI-powered precision health," Verily Chief Revenue Officer Bharat Rajagopal stated. "By integrating Segmed's curated real-world imaging and associated clinical data into Pre, we are empowering researchers with the comprehensive, multimodal data resources they need to unlock new insights and accelerate discovery." This partnership reflects Segmed's ongoing efforts to support patient-centered, data-driven healthcare innovation by enabling secure, scalable access to real-world imaging data and associated clinical data within trusted research environments. Segmed Inc. streamlines access to diverse, high-quality real-world data, including medical imaging and clinical records, for biopharmaceutical R&D, AI development, and medical device innovation. With a global network of healthcare partners across five continents, Segmed provides researchers with approximately 150 million de-identified, standardized imaging datasets through its proprietary platform, empowering safer, faster, and more equitable healthcare advancements. Verily is a data platform and technology company purpose-built to power AI for precision health. Verily offers AI-enabled solutions that transform multimodal health data into insights and actions that accelerate research and improve care for individuals and communities. Verily is positioned at the intersection of technology, data science, and healthcare to create tools that accelerate evidence generation, enable more personalized care, and help manage disease at a population level.